Fountzilas, E. Koliou, G.-A. Vozikis, A. Rapti, V. Nikolakopoulos, A. Boutis, A. Christopoulou, A. Kontogiorgos, I. Karageorgopoulou, S. Lalla, E. Tryfonopoulos, D. Boukovinas, I. Rapti, C. Nikolaidi, A. Karteri, S. Moirogiorgou, E. Binas, I. Mauri, D. Aravantinos, G. Zagouri, F. Saridaki, Z. Psyrri, A. Bafaloukos, D. Koumarianou, A. Res, E. Linardou, H. Mountzios, G. Razis, E. Fountzilas, G. Koumakis, G., Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: The experience of the Hellenic Cooperative Oncology Group, ESMO open, (5), 2020, BMJ Publishing Group,